MO - Altria Group, Inc.

NYSE - NYSE Delayed Price. Currency in USD
50.89
-1.46 (-2.79%)
At close: 4:01PM EST

50.99 +0.10 (0.20%)
After hours: 6:23PM EST

Stock chart is not supported by your current browser
Previous Close52.35
Open52.36
Bid50.99 x 3200
Ask51.00 x 800
Day's Range50.69 - 52.44
52 Week Range50.69 - 74.38
Volume10,671,452
Avg. Volume8,734,171
Market Cap95.625B
Beta (3Y Monthly)-0.14
PE Ratio (TTM)9.04
EPS (TTM)5.63
Earnings DateJan 30, 2019 - Feb 4, 2019
Forward Dividend & Yield3.20 (6.07%)
Ex-Dividend Date2018-12-24
1y Target Est64.49
Trade prices are not sourced from all markets
  • Final Trades: LOW, MO & more
    CNBC Videos20 minutes ago

    Final Trades: LOW, MO & more

    The "Fast Money" traders share their final trades of the day, including Lowe's, Altria Group, the XLU utilities ETF and Target.

  • Investing.com1 hour ago

    Altria Falls 3%

    Investing.com - Altria (NYSE:MO) fell by 3.02% to trade at $50.77 by 15:25 (20:25 GMT) on Tuesday on the NYSE exchange.

  • Citron Boosts Shorted Pot Stock: Industry Dynamics Have Just Changed
    Investor's Business Daily2 hours ago

    Citron Boosts Shorted Pot Stock: Industry Dynamics Have Just Changed

    One of Wall Street's most notorious short-sellers — and a onetime skeptic of marijuana stocks — is giving Canadian cannabis producer Aphria a big assist.

  • Philip Morris Stock Tanks on Credit Suisse Downgrade
    Market Realist4 hours ago

    Philip Morris Stock Tanks on Credit Suisse Downgrade

    Today, Reuters reported that Credit Suisse downgraded Philip Morris International (PM) from “neutral” to “underperform” and lowered its price target to $74 from $92. The new price target represents a fall of 9.1% from the company’s December 17 closing price of $81.40. Among the 19 analysts who follow Philip Morris, 52.6% recommend a “buy,” 36.8% recommend a “hold,” and 10.5% recommend a “sell.” On average, analysts have given the stock a price target of $93.25, which represents an upside potential of 14.6% from its closing price on December 17.

  • InvestorPlace6 hours ago

    Check Your Risk Tolerance Before Inhaling Aphria Stock

    Although it has risen from recent lows, the pain for Aphria (NYSE:APHA) stock continues. With the credibility of Aphria’s management called into question by short-seller research reports, APHA has now fallen below Cronos (NASDAQ:CRON) in market cap. With APHA trading at a much lower valuation than its peers, the case for a risky contrarian play in Aphria stock only grows stronger.

  • InvestorPlace8 hours ago

    What to Expect From Cronos Stock In the Latest Pot Hype Cycle

    Marijuana stocks like Cronos Group (NASDAQ:CRON) stock have spent 2018 in the hype cycle. The hype cycle is a term common to technology investors. Now, just as things settle down, Altria (NYSE:MO), formerly the U.S. unit of Philip Morris, is paying $1.8 billion to get 45% of Cronos, a medical marijuana company based in Canada.

  • The Zacks Analyst Blog Highlights: McDonald???s, AbbVie, Altria, Wells Fargo and Disney
    Zacks8 hours ago

    The Zacks Analyst Blog Highlights: McDonald???s, AbbVie, Altria, Wells Fargo and Disney

    The Zacks Analyst Blog Highlights: McDonald???s, AbbVie, Altria, Wells Fargo and Disney

  • Can Altria (MO) Rebound From a Terrible 2018?
    Zacks9 hours ago

    Can Altria (MO) Rebound From a Terrible 2018?

    Stringent FDA regulations have led to fading cigarette sales that are plaguing the performance of Altria. Nevertheless, growth in RRPs looks encouraging.

  • 3 Stocks Poised for Huge Growth Over the Next Decade
    Motley Fool11 hours ago

    3 Stocks Poised for Huge Growth Over the Next Decade

    Cronos Group, Welltower, and Zscaler will ride the next supertrend wave.

  • InvestorPlace12 hours ago

    Cronos Stock Should Be a Buy — Just Not Yet

    Cronos executed a potentially transformative deal with tobacco giant Altria (NYSE:MO). Indeed, I’m somewhat surprised by the reaction, in terms of both Cronos stock and pot stocks on the whole. As rumors of a deal flew earlier this month, I wrote that an executed agreement would be transformative for CRON stock, and the industry.

  • Altria (MO) Stock Moves -0.72%: What You Should Know
    Zacksyesterday

    Altria (MO) Stock Moves -0.72%: What You Should Know

    Altria (MO) closed the most recent trading day at $52.35, moving -0.72% from the previous trading session.

  • Makers of flavored e-cigarettes face ‘a make-or-break year’ in Washington, analyst says
    MarketWatchyesterday

    Makers of flavored e-cigarettes face ‘a make-or-break year’ in Washington, analyst says

    “2019 will be a make-or-break year for alternative tobacco product manufacturers to regain control of the flavors debate,” says Stefanie Miller of Height Capital Markets in a note Friday.

  • 3 Top Dividend Stocks With Yields Over 4%
    Motley Foolyesterday

    3 Top Dividend Stocks With Yields Over 4%

    These three stocks offer big yields but trade at low valuations.

  • InvestorPlaceyesterday

    Why Tilray Stock Shouldn’t Take the Heat for Aphria’s Problem

    You can never take anything for granted in the legal-cannabis sector, and Tilray (NASDAQ:TLRY) offered the latest cautionary tale. After several trading sessions stabilizing around the $100 level suggested relative normalization, Tilray stock entered a full-blown meltdown. Since the start of the week, TLRY has hemorrhaged over 25% of market value.

  • Should You Buy Philip Morris International for Its 5% Dividend Yield?
    Motley Fool2 days ago

    Should You Buy Philip Morris International for Its 5% Dividend Yield?

    Has the tobacco giant become an undervalued income investment?

  • Better Marijuana Stock: Cronos Group vs. Scotts Miracle-Gro
    Motley Fool2 days ago

    Better Marijuana Stock: Cronos Group vs. Scotts Miracle-Gro

    Which stock wins in a matchup between a high-flying Canadian marijuana producer and a beaten-down top supplier to the U.S. cannabis industry?

  • 5 Things That Really Matter When Investing in Marijuana Stocks
    Motley Fool2 days ago

    5 Things That Really Matter When Investing in Marijuana Stocks

    Hint: Peak production potential isn't one of them.

  • Better Buy: Canopy Growth vs. Cronos Group
    Motley Fool3 days ago

    Better Buy: Canopy Growth vs. Cronos Group

    Big deals for both of these marijuana producers have excited investors. But which stock will be the bigger winner down the road?

  • 3 Marijuana Stocks That Could Land a Big-Name Partner in 2019
    Motley Fool3 days ago

    3 Marijuana Stocks That Could Land a Big-Name Partner in 2019

    Cannabis dealmaking is likely to continue into the new year.

  • Better Buy: PepsiCo vs. Altria
    Motley Fool3 days ago

    Better Buy: PepsiCo vs. Altria

    Which of these dividend stocks is the best choice for your portfolio?

  • This Small-Cap Cannabis Stock Is Up Big in a Down Market. Here's Why.
    Motley Fool4 days ago

    This Small-Cap Cannabis Stock Is Up Big in a Down Market. Here's Why.

    Medical Marijuana's stock has started to heat up. Here's why.

  • 12 Stocks You Should Never Sell
    Kiplinger4 days ago

    12 Stocks You Should Never Sell

    Hopping in and out of stocks tends to do more harm than good to your portfolio. Fortunately, most of the time, investors are content to sit back and let time do the heavy lifting. Every now and then, however, an uninterrupted market-wide rally (such as the one we saw in 2017) followed by a couple of major corrections (such as the ones we've seen in 2018) inspires a more active approach. Buying every dip last year was a bulletproof strategy; steering clear of this year's big dips would've left most investors far better off. But broadly speaking, investors shouldn't embrace that short-term mindset. Buy-and-hold is a time-tested strategy that helps investors avoid trying to time the market (which even experts can't reliably do) and making poor emotional decisions. With that as a backdrop, here are a dozen stocks to never sell. Many buy-and-holders are looking to reset their portfolios as the new year begins. If you hold any of the stocks, don't stop ... and if you're looking to buy, be ready to commit. Each company has plenty to success that their history of success should continue for years to come. And each operates in an industry that won't go away anytime soon. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond

  • IPO-Edge.com4 days ago

    High Times Rolls Up Another Conference with BIG Show Acquisition – More M&A in Store?

    High Times Purchases B2B Conference Operator Buyers Industry Guide By John Jannarone The parent of High Times magazine has acquired a major cannabis event operator just days after clearing most of the debt from its balance sheet, a likely sign of more deals to come. High Times Holding Corp, which operates the renowned Cannabis Cup […]

  • IPO Edge4 days ago

    High Times Rolls Up Another Conference with BIG Show Acquisition – More M&A in Store?

    High Times Purchases B2B Conference Operator Buyers Industry Guide By John Jannarone The parent of High Times magazine has acquired a major cannabis event operator just days after clearing most of the debt from its balance sheet, a likely sign of more deals to come. High Times Holding Corp, which operates the renowned Cannabis Cup […]